SAN DIEGO, CA – Medical Marijuana, Inc. (OTC: MJNA) recognizes and applauds the significant accomplishment of Ohio as the 25th U.S. state or district to allow qualified patients access to medical cannabis (marijuana) for medicinal use. Ohio Gov. John Kasich signed the bill into law on June 9, 2016, three days after a new Quinnipiac University poll that found 89 percent of U.S. voters support legalization of medical marijuana.
Including U.S. territories Puerto Rico and Guam, as well as the District of Columbia, Ohio’s milestone achievement translates to more than 50% of the U.S. with full-spectrum medical cannabis laws enacted. In addition, there are 16 U.S. states with limited medical cannabis access laws enacted, which brings the total of all U.S. states, districts or territories with some form of cannabis law to 43.
“We want to commend the members of Ohio’s General Assembly for passing this bill in such a swift manner and for listening and reacting to Ohio residents who overwhelmingly back medical marijuana,” said Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana Inc.“Ohio’s approval of medical marijuana is a watershed moment for the medical marijuana industry. We have reached a tipping point in the U.S. that could lead to real marijuana reform at the federal level,” Titus added.
According to a new national poll by Quinnipiac University on June 6, 2016, nearly every single voter in the U.S., or 89 percent, support allowing adults to legally use marijuana for medical purposes if prescribed by a doctor. The poll also found that medical marijuana is a nonpartisan issue, with 81 percent of Republicans, 94 percent of Democrats, and 93 percent of independent voters all saying medical marijuana should be legal.
“Also noteworthy in many medical-marijuana-legal states is that we are now seeing an expansion of the number of potential allowable indications for doctors to recommend medicinal cannabis to patients,” added Titus. “In Ohio, as many as 21 medical conditions are slated to be allowed for patients to qualify for medical marijuana, while Pennsylvania recently named 18 qualifying medical conditions under its program. The greater the number of medical indications that states allow for qualification to receive medical marijuana, the greater the number of residents will receive access and benefit.”
In Ohio, patients qualify for medical marijuana if they have one of the following 21 conditions: HIV/AIDS; Alzheimer’s disease; Amyotrophic lateral sclerosis (ALS); cancer; chronic traumatic encephalopathy (CTE); Crohn’s disease; epilepsy or another seizure disorder; fibromyalgia; glaucoma; hepatitis C; inflammatory bowel disease; multiple sclerosis; pain that is chronic, severe, and intractable; Parkinson’s disease; post-traumatic stress disorder; sickle cell anemia; spinal cord disease or injury; Tourette’s syndrome; traumatic brain injury; and ulcerative colitis. Individuals can petition the state medical board to add conditions.
Medical Marijuana, Inc.’s current investments are in both the marijuana services and industrial hemp cannabidiol (CBD) industries; industrial hemp-based products are available to ship to all 50 states, districts, territories and more than 40 countries. As evidenced by the Company’s international distribution of hemp CBD retail products to Brazil, Mexico and Paraguay by way of government-issued import permits, the global demand for legal cannabis products is on the rise. Medical Marijuana Inc. is also focused on investments that are developing cannabis-based pharmaceutical drug development for global distribution.
When Federal legalization of marijuana occurs in the U.S., Medical Marijuana, Inc. will easily transition into operational expansion of marijuana-derived product production, marketing and distribution. For more information on Medical Marijuana, Inc. visit the company’s website.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
P. 888-829- 0070
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500